Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11 Pt 1
pubmed:dateCreated
2005-11-14
pubmed:abstractText
Folate metabolism supports the synthesis of nucleotides as well as the transfer of methyl groups. Polymorphisms in folate-metabolizing enzymes have been shown to affect risk of colorectal neoplasia and other malignancies. Using data from a population-based incident case-control study (1,600 cases and 1,962 controls), we investigated associations between genetic variants in the reduced folate carrier (RFC), thymidylate synthase (TS), methionine synthase (MTR), and 5,10-methylenetetrahydrofolate reductase (MTHFR) and colon cancer risk. The TS enhancer region (TSER) variant was associated with a reduced risk among men [2rpt/2rpt versus 3rpt/3rpt wild-type; odds ratio (OR), 0.7; 95% confidence interval, 0.6-0.98] but not women. When combined genotypes for both TS polymorphisms (TSER and 3'-untranslated region 1494delTTAAAG) were evaluated, ORs for variant genotypes were generally below 1.0, with statistically significantly reduced risks among women. Neither MTR D919G nor RFC 80G>A polymorphisms were associated with altered colon cancer risk. Because folate metabolism is characterized by interrelated reactions, we evaluated gene-gene interactions. Genotypes resulting in reduced MTHFR activity in conjunction with low TS expression were associated with a reduced risk of colon cancer. When dietary intakes were taken into account, individuals with at least one variant TSER allele (3rpt/2rpt or 2rpt/2rpt) were at reduced risk in the presence of a low folate intake. This study supports findings from adenoma studies indicating that purine synthesis may be a relevant biological mechanism linking folate metabolism to colon cancer risk. A pathway-based approach to data analysis is needed to help discern the independent and combined effects of dietary intakes and genetic variability in folate metabolism.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1055-9965
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2509-16
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16284371-5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase, pubmed-meshheading:16284371-Adenoma, pubmed-meshheading:16284371-Adult, pubmed-meshheading:16284371-Aged, pubmed-meshheading:16284371-Case-Control Studies, pubmed-meshheading:16284371-Colonic Neoplasms, pubmed-meshheading:16284371-Diet, pubmed-meshheading:16284371-Female, pubmed-meshheading:16284371-Folic Acid, pubmed-meshheading:16284371-Genetic Predisposition to Disease, pubmed-meshheading:16284371-Genotype, pubmed-meshheading:16284371-Humans, pubmed-meshheading:16284371-Male, pubmed-meshheading:16284371-Membrane Transport Proteins, pubmed-meshheading:16284371-Middle Aged, pubmed-meshheading:16284371-Odds Ratio, pubmed-meshheading:16284371-Polymorphism, Genetic, pubmed-meshheading:16284371-Reduced Folate Carrier Protein, pubmed-meshheading:16284371-Thymidylate Synthase
pubmed:year
2005
pubmed:articleTitle
Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer.
pubmed:affiliation
Cancer Prevention Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4-B402 Seattle, WA 98109-1024, USA. nulrich@fhcrc.org
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural